Votre navigateur ne supporte pas le javascript FNRS News
DONATE | |

FNRS News

The AstraZeneca Foundation's 2025 Scientifics Awards recognise three promising projects that could revolutionise the medical world

Three young scientists have been recognised for their groundbreaking research into rare diseases and conditions. The AstraZeneca Foundation Awards are presented by an independent jury, made up of the FNRS and the FWO.

Dr Robert Prior (VIB/KU Leuven) himself suffers from Charcot-Marie-Tooth disease (he was diagnosed at the age of 15), a hereditary disease that causes muscle weakness and loss of sensation. Today, he is developing stem cell models to better understand the disease and accelerate future therapies. 

Professor Sarah Verhulst (Hearing Technology @WAVES/UGent) has designed anAI-driven hearing test that makes the very first signs of hearing damage visible, so that it can be prevented from getting worse more quickly.

Professor Robin Vos (UZ Leuven/KU Leuven) and his team have developed new methods for the early detection of chronic lung transplant rejection, enabling much more targeted treatment. 

Each year, an independent jury, made up of the National Fund for Scientific Research (FNRS) and the Fonds voor Wetenschappelijk Onderzoek (FWO), nominates three young winners for their innovative research. Each of them receives €25,000 to fund their further research.

See the press release...

Astra-Zeneca-2025


Opening of the call Grants and Fellowships 2026

The call Grants and Fellowships 2026 is open on e-space. The following instruments are concerned:

Postdoctoral researcher

  • Postdoctoral Researcher - CR
  • Postdoctoral Medical Doctor Applicant to an MSc - CSPD
  • Postdoctoral Clinical Master Specialist - SPD
  • Postdoctoral Clinical Master Specialist renewal – SPD-REN
  • Clinical Researcher - CCL
  • Clinical Researcher renewal – CCL-REN 
  • Research Associate– CQ
  • Senior Research Associate – MR
  • Research Director – DR
  • Ulysse Incentive Grant for Mobility in Scientific Research extension – MISU-PROL

Doctoral researcher

  • Research Fellow - ASP
  • Research Fellow renewal – ASP-REN
  • Special Doctoral Grant - BSD
  • Medical Doctor Applicant to an MSc and a Ph.D. - CSD
  • Medical Doctor Applicant to an MSc and a Ph.D. renewal – CSD-REN
  • Clinical Master Specialist Applicant to a Ph.D. - SD
  • Clinical Master Specialist Applicant to a Ph.D. renewal – SD-REN
  • Veterinary MD. Ph.D. Student - VETE-CCD
  • Veterinary MD. Ph.D. Student renewal – VETE-CCD-REN
See the calendar for the deadlines of each call.
Consult the Rules and the Mini-Guide EN.
More info on the Rules & Guides page.

Bourse-et-mandat-2025-EN

 


Results of the first AMG-Pediatrics call

On December 9, 2025, the FNRS Board of Directors awarded 3 AMG-Pediatrics.

This was the first call of its kind, made possible thanks to private sponsorship.

The AMG-Pediatrics supports research projects covering all pathologies affecting pediatric or fetal patients/subjects, including infectious diseases and vaccinology, immune deficiencies, cardiovascular, respiratory and metabolic diseases, congenital, developmental, neurological and psychiatric disorders, cancers, etc.

AMGPediatrics-Resultats-2025-EN


Audacious Medical Grant – Neuro (AMG-Neuro ) 2025 – Results of the call

On December 9, 2025, the FNRS Board of Directors awarded 4 AMG-Neuro.

The Audacious Medical Grant (AMG) is an instrument financed by private donations and bequests received by the FNRS.

It supports original, bold and creative medical or biomedical research projects that are unable to find support through traditional funding channels due to a lack of preliminary data, the absence of previous work or an unusual methodology.

AMGNeuro-Resultats-2025-EN


Research projects WelCHANGE

On December 9, 2025, the FNRS Board of Directors decided to fund 19 WelCHANGE research projects.

WelCHANGE FNRS is a funding program for research projects led by a principal investigator in the humanities and social sciences, with potential societal impacts.

The current presented list of beneficiaries is subject to the approval of the Government Commissioner of the French-speaking Community of Belgium. This reservation will be lifted on 16 December 2025 and mailing should be sent out on the same day.

Welchange-Resultats-2025-EN


Contact us

Fund for Scientific Research - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

BE55 0016 0000 0044

Contact the FNRS